Literature DB >> 29495082

Protective effect of melatonin in the diabetic rat retina.

Saeed Mehrzadi1, Manijeh Motevalian1, Mozhgan Rezaei Kanavi2, Iman Fatemi3,4, Habib Ghaznavi5, Mansoor Shahriari6.   

Abstract

Diabetic retinopathy (DR) is one of the most common and serious microvascular complications of diabetes. The aim of this study was to evaluate the effects of melatonin (MEL) on retinal injury in diabetic rats. In this study, 21 rats were randomly divided into three groups: control, diabetic, and diabetic + MEL. Streptozotocin was used to induce diabetes at a dose of 50 mg/kg, i.p., and blood glucose was measured to choose the diabetic rats for the study. MEL (20 mg/kg) was given orally for 7 weeks in diabetic rats starting 1 week after induction of diabetes. After 8 weeks, the groups were compared in terms of mean scores of fluorescein leakage, using fluorescein angiography. Reactive oxygen species (ROS) and malondialdehyde (MDA) levels were estimated in retina using commercially available assays. Structural changes in retinas were evaluated by light microscopy. Results showed that diabetes significantly increased the mean scores of fluorescein leakage, and MDA and ROS levels compared to control group. Treatment of the diabetic rats with MEL for 7 weeks prevented the alterations induced by diabetes in comparison with the diabetic control group.Based on these findings, it can be concluded that MEL might have beneficial effects in prevention of DR.
© 2018 Société Française de Pharmacologie et de Thérapeutique.

Entities:  

Keywords:  antioxidant; diabetic retinopathy; fluorescein angiography; melatonin

Mesh:

Substances:

Year:  2018        PMID: 29495082     DOI: 10.1111/fcp.12361

Source DB:  PubMed          Journal:  Fundam Clin Pharmacol        ISSN: 0767-3981            Impact factor:   2.748


  9 in total

Review 1.  Inherited Retinal Dystrophies: Role of Oxidative Stress and Inflammation in Their Physiopathology and Therapeutic Implications.

Authors:  Isabel Pinilla; Victoria Maneu; Laura Campello; Laura Fernández-Sánchez; Natalia Martínez-Gil; Oksana Kutsyr; Xavier Sánchez-Sáez; Carla Sánchez-Castillo; Pedro Lax; Nicolás Cuenca
Journal:  Antioxidants (Basel)       Date:  2022-05-30

Review 2.  Therapeutic potential of melatonin as a chronobiotic and cytoprotective agent in diabetes mellitus.

Authors:  Fareha Wajid; Raju Poolacherla; Fatiha Kabir Mim; Amna Bangash; Ian H Rutkofsky
Journal:  J Diabetes Metab Disord       Date:  2020-07-21

Review 3.  Circadian rhythms in diabetic retinopathy: an overview of pathogenesis and investigational drugs.

Authors:  Ashay D Bhatwadekar; Varun Rameswara
Journal:  Expert Opin Investig Drugs       Date:  2020-12-02       Impact factor: 6.206

Review 4.  Update on the Effects of Antioxidants on Diabetic Retinopathy: In Vitro Experiments, Animal Studies and Clinical Trials.

Authors:  Jose Javier Garcia-Medina; Elena Rubio-Velazquez; Elisa Foulquie-Moreno; Ricardo P Casaroli-Marano; Maria Dolores Pinazo-Duran; Vicente Zanon-Moreno; Monica Del-Rio-Vellosillo
Journal:  Antioxidants (Basel)       Date:  2020-06-26

5.  Fushiming Capsule Attenuates Diabetic Rat Retina Damage via Antioxidation and Anti-Inflammation.

Authors:  Mengshan He; Pan Long; Lunfeng Guo; Mingke Zhang; Siwang Wang; Hongling He
Journal:  Evid Based Complement Alternat Med       Date:  2019-07-18       Impact factor: 2.629

6.  Effect of Musk Tongxin Dropping Pill on Myocardial Remodeling and Microcirculation Dysfunction in Diabetic Cardiomyopathy.

Authors:  Jingjing Zhao; Yan Zhou; Huahua Liu; Zhaohai Zheng; Shuqing Liu; Jiahao Peng; Hangyuan Guo; Weiliang Tang; Fang Peng
Journal:  Evid Based Complement Alternat Med       Date:  2021-03-18       Impact factor: 2.629

Review 7.  Effects of Melatonin on Diabetic Neuropathy and Retinopathy.

Authors:  Klausen Oliveira-Abreu; José Cipolla-Neto; Jose Henrique Leal-Cardoso
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

8.  Melatonin Maintains Inner Blood-Retinal Barrier by Regulating Microglia via Inhibition of PI3K/Akt/Stat3/NF-κB Signaling Pathways in Experimental Diabetic Retinopathy.

Authors:  Lei Tang; Chaoyang Zhang; Lixia Lu; Haibin Tian; Kun Liu; Dawei Luo; Qinghua Qiu; Guo-Tong Xu; Jingfa Zhang
Journal:  Front Immunol       Date:  2022-03-15       Impact factor: 7.561

Review 9.  Circadian dysrhythmia-linked diabetes mellitus: Examining melatonin's roles in prophylaxis and management.

Authors:  Adejoke Y Onaolapo; Olakunle J Onaolapo
Journal:  World J Diabetes       Date:  2018-07-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.